Evidence map›Paper›PMID 31452839›Full record

ArticleOncotarget2019

Methylation alteration of

Eleonora Loi, Loredana Moi, Antonio Fadda, Giannina Satta, Mariagrazia Zucca, Sonia Sanna, Shadi Amini Nia, Giuseppina Cabras, Marina Padoan, Corrado Magnani and 9 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Frontiers in immunology · 2022
    Article
  12. DNA methylation alterations caused byFrontiers in cellular and infection microbiology · 2022
    Review
  13. Article
  14. Truncating variants in the SHANK1 gene are associated with a spectrum of neurodevelopmental disorders.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Eleonora LoiDepartment of Biomedical Sciences, Unit of Biology and Genetics, University of Cagliari, Cagliari, Italy.
Loredana MoiDepartment of Biomedical Sciences, Unit of Biology and Genetics, University of Cagliari, Cagliari, Italy.
Antonio FaddaDepartment of Biomedical Sciences, Unit of Biology and Genetics, University of Cagliari, Cagliari, Italy.
Giannina SattaDepartment of Medical Sciences and Public Health, Occupational Health Unit, University of Cagliari, Cagliari, Italy.
Mariagrazia ZuccaDepartment of Biomedical Sciences, Cytomorphology Unit, University of Cagliari, Cagliari, Italy.
Sonia SannaDepartment of Biomedical Sciences, Cytomorphology Unit, University of Cagliari, Cagliari, Italy.
Shadi Amini NiaDepartment of Medical Sciences and Public Health, Occupational Health Unit, University of Cagliari, Cagliari, Italy.
Giuseppina CabrasUnit of Hematology, A. Businco Oncology Hospital, Cagliari, Italy.
Marina PadoanDepartment of Medical Sciences, Unit of Medical Statistics and Cancer Epidemiology, University of Eastern Piedmont, Novara, Italy.
Corrado MagnaniDepartment of Medical Sciences, Unit of Medical Statistics and Cancer Epidemiology, University of Eastern Piedmont, Novara, Italy.
Lucia MiligiInstitute of Oncology Studies and Prevention, Florence, Italy.
Sara PiroInstitute of Oncology Studies and Prevention, Florence, Italy.
Davide GentiliniDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Maria Grazia EnnasDepartment of Biomedical Sciences, Cytomorphology Unit, University of Cagliari, Cagliari, Italy.
Melissa C SoutheyPrecision Medicine, Monash University, Melbourne, Melbourne, Australia.
Graham G GilesCancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia.
Nicole Wong DooCancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia.
Pierluigi CoccoDepartment of Medical Sciences and Public Health, Occupational Health Unit, University of Cagliari, Cagliari, Italy.
Patrizia ZavattariDepartment of Biomedical Sciences, Unit of Biology and Genetics, University of Cagliari, Cagliari, Italy.
University of Cagliari · ITCancer Council Victoria · AUUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Melbourne · AUUniversity of Pavia · ITUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease characterized by the clonal expansion of malignant B cells. To predict the clinical course of the disease, the identification of diagnostic biomarkers is urgently needed. Aberrant methylation patterns may predict CLL development and its course, being very early changes during carcinogenesis. Our aim was to identify CLL specific methylation patterns and to evaluate whether methylation aberrations in selected genes are associated with changes in gene expression. Here, by performing a genome-wide methylation analysis, we identified several CLL-specific methylation alterations. We focused on the most altered one, at a CpG island located in the body of

Indexed as

cancer methylation alterationdiagnostic biomarkerspredictive biomarkersprognostic biomarkersSHANK1

Identifiers

PMID31452839
PMCPMC6697638
OpenAlexW2987645963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.